Randomized, open-label, parallel-group, multi-centre phase II clinical trial of active cellular immunotherapy with prepapration DCVAC/PCa in patients with localized high-risk prostate cancer after primary radiotherapy

Trial Profile

Randomized, open-label, parallel-group, multi-centre phase II clinical trial of active cellular immunotherapy with prepapration DCVAC/PCa in patients with localized high-risk prostate cancer after primary radiotherapy

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Jul 2016

At a glance

  • Drugs Stapuldencel-T (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Sponsors SOTIO
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top